Fortress Biotech Inc reports results for the quarter ended in March - Earnings Summary

Fortress Biotech

16/05/2023 19:20

* Fortress Biotech Inc  FBIO.OQ  reported a quarterly
adjusted
loss of 21 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 20 cents per share.
    * Revenue fell 48.1% to $12.43 million from a year ago;
analysts
expected $20.27 million. 
    * Fortress Biotech Inc's reported EPS for the quarter was a
loss
of 21 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Fortress Biotech Inc shares had fallen by 13.8% this
quarter and
gained 7.9% so far this year.
    * The company reported a quarterly loss of $21.54 million.
    * Wall Street's median 12-month price target for Fortress
Biotech
Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
16 at 06:20 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.20          -0.21          Missed
 Dec. 31 2022      -0.22          -0.30          Missed
 Sep. 30 2022      -0.27          -0.25          Beat
 Jun. 30 2022      -0.21          -0.24          Missed